14.08.2012 Views

Labelling Review row-Online

Labelling Review row-Online

Labelling Review row-Online

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Primary Antibodies<br />

CD35<br />

Clone RLB25<br />

1 mL, 0.1 mL lyophilized NCL-CD35 F P (Enzyme)<br />

The CD35 antigen, also known as CR1 or C3b/C4b R, is a transmembrane<br />

protein of 160 to 250 kD which binds complement components C3b and C4b.<br />

It mediates phagocytosis by neutrophils and monocytes of particles coated<br />

with C3b or C4b. CD35 antigen has an inhibitory effect on complement<br />

activation by both the classical and alternative pathways. CD35 antigen is<br />

reported to be found on erythrocytes, B cells, a subset of T cells, monocytes,<br />

macrophages cultured in vitro, neutrophils, eosinophils, glomerular<br />

podocytes and follicular dendritic cells. Decreased levels of CD35 antigen<br />

has been reported on B cells in patients with HIV infection.<br />

Normal human tonsil: immunohistochemical staining for CD35 antigen using NCL-CD35. Note<br />

intense membrane staining of follicular dendritic cells. Paraffin section.<br />

CD37<br />

Clone CT1<br />

1 mL lyophilized NCL-CD37 F P (HIER)<br />

CD37 antigen is a member of the TM4 superfamily with a molecular weight of<br />

40 to 52 kD. CD37 antigen was originally defined as an antigen of mature<br />

B lymphocytes where it is highly expressed. It is reported not to be<br />

expressed on pre-B cells or plasma cells and is expressed only at low level<br />

in T cells, neutrophils, monocytes and some myelomonocytic leukemia cells.<br />

NK cells, platelets and erythrocytes also do not express CD37 antigen. CD37<br />

antigen on B cells associates non-covalently with MHC class II, CD19 and<br />

CD21 antigens and with other TM4 superfamily molecules CD53, CD81 and<br />

CD82.<br />

/78<br />

For detailed information on all products please visit our website:<br />

www.leica-microsystems.com<br />

CD38<br />

Clone SPC32<br />

1 mL, 0.1 mL lyophilized NCL-CD38-290 F P (HIER)<br />

1 mL liquid NCL-L-CD38-290 F P (HIER)<br />

The CD38 molecule is a type II single transmembrane glycoprotein with a<br />

molecular weight of 46 kD. It is an ectoenzyme with the activities of ADPribosyl<br />

cyclase, cyclic ADP-ribose hydrolase, NAD glycohydrolase and is<br />

involved in both the formation and hydrolysis of cADPR, a second<br />

messenger that regulates the mobilization of intracellular Ca 2+ ions.<br />

Although the CD38 molecule was originally identified as a T lymphocyte<br />

differentiation antigen, it is reported to be expressed in a wide range of cells<br />

and tissues. CD38 antigen can deliver potent g<strong>row</strong>th and differentiation<br />

signals to lymphoid and myeloid cells. It is found on immature cells of the B<br />

and T cell lineages but not on most mature resting peripheral lymphocytes. It<br />

is also present on thymocytes, pre-B cells, germinal center B cells, mitogenactivated<br />

T cells, Ig-secreting plasma cells, monocytes, NK cells, erythroid<br />

and myeloid progenitors in the bone mar<strong>row</strong> and brain cells. CD38 antigen<br />

has also been reported in neurofibrillary tangles, the pathological indicator<br />

of Alzheimer's disease that occurs in the neuronal perikarya and proximal<br />

dendrites.<br />

Chronically inflamed human bronchus: immunohistochemical staining for CD38 antigen using<br />

NCL-CD38-290. Note intense membrane staining of infiltrating activated T lymphocytes.<br />

Paraffin section.<br />

CD39<br />

Clone 22A9<br />

1 mL lyophilized NCL-CD39 P (HIER)<br />

CD39 antigen is a transmembrane glycoprotein found on mature<br />

B lymphocytes, follicular dendritic cells, endothelial cells, activated T cells,<br />

NK cells and Langerhans cells. It is also known as E-type apyrase which<br />

hydrolyses extracellular ATP and ADP, a function important to homotypic<br />

adhesion and platelet aggression. CD39 antigen expressing cells may<br />

provide protection from the toxic effects of ATP leaked from damaged cells.<br />

CD39 antigen may enable tumor cells to reduce contact with T lymphocytes<br />

and escape immunological recognition. Increased levels of CD39 antigen<br />

expression are also reported to be associated with increased ectoATPase<br />

activity that occurs during the progression of melanomas.<br />

Human lymph node, B cell lymphoma: immunohistochemical staining for CD39 antigen using<br />

NCL-CD39. Note intense membrane staining of tumor cells. Paraffin section.<br />

Products in this catalog are subject to regulatory approval.<br />

This catalog is not for use in the USA.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!